Literature DB >> 11593836

Aspirin use for the prevention of cardiovascular disease: the British Women's Heart and Health Study.

D A Lawlor1, C Bedford, M Taylor, S Ebrahim.   

Abstract

Low dose aspirin is effective, safe, and economical in the secondary prevention of cardiovascular disease. We have found that only one-third of post-menopausal women with cardiovascular disease are using aspirin and that the majority of women who are using aspirin are doing so for primary prevention. Improvements in this area of medical practice are both necessary and feasible.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11593836      PMCID: PMC1314103     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  5 in total

1.  Who benefits from medical interventions?

Authors:  G D Smith; M Egger
Journal:  BMJ       Date:  1994-01-08

2.  Aspirin use in middle-aged men with cardiovascular disease: are opportunities being missed?

Authors:  A K McCallum; P H Whincup; R W Morris; A Thomson; M Walker; S Ebrahim
Journal:  Br J Gen Pract       Date:  1997-07       Impact factor: 5.386

3.  Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis.

Authors:  S Derry; Y K Loke
Journal:  BMJ       Date:  2000-11-11

4.  Sex differences in risk factors, treatment and mortality after acute myocardial infarction: an observational study.

Authors:  B Hanratty; D A Lawlor; M B Robinson; R J Sapsford; D Greenwood; A Hall
Journal:  J Epidemiol Community Health       Date:  2000-12       Impact factor: 3.710

5.  British Regional Heart Study: cardiovascular risk factors in middle-aged men in 24 towns.

Authors:  A G Shaper; S J Pocock; M Walker; N M Cohen; C J Wale; A G Thomson
Journal:  Br Med J (Clin Res Ed)       Date:  1981-07-18
  5 in total
  1 in total

1.  Gene-centric association signals for haemostasis and thrombosis traits identified with the HumanCVD BeadChip.

Authors:  Tom R Gaunt; Delilah Zabaneh; Steve E Humphries; Ian N Day; Sonia Shah; Anna Guyatt; Christophe Ladroue; Meena Kumari; Fotios Drenos; Tina Shah; Philippa J Talmud; Juan Pablo Casas; Gordon Lowe; Ann Rumley; Debbie A Lawlor; Mika Kivimaki; John Whittaker; Aroon D Hingorani
Journal:  Thromb Haemost       Date:  2013-08-29       Impact factor: 5.249

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.